These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37063262)

  • 1. Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines.
    von Hofsten S; Langer MK; Korelin K; Magnussen S; Ausbacher D; Anderssen T; Salo T; Strøm MB; Bayer A; Al-Samadi A; Berge G
    Front Pharmacol; 2023; 14():1141669. PubMed ID: 37063262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines.
    von Hofsten S; Paulsen MH; Magnussen SN; Ausbacher D; Kranz M; Bayer A; Strøm MB; Berge G
    Sci Rep; 2022 Sep; 12(1):15586. PubMed ID: 36114339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.
    Maushagen R; Reers S; Pfannerstill AC; Hahlbrock A; Stauber R; Rahmanzadeh R; Rades D; Pries R; Wollenberg B
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1261-71. PubMed ID: 27038158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.
    De Azevedo J; Mourtada J; Bour C; Devignot V; Schultz P; Borel C; Pencreach E; Mellitzer G; Gaiddon C; Jung AC
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
    Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
    J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.
    Cooper T; Biron VL; Fast D; Tam R; Carey T; Shmulevitz M; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):8. PubMed ID: 25890191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC.
    Zhao YY; Lian JX; Lan Z; Zou KL; Wang WM; Yu GT
    Oral Dis; 2023 Apr; 29(3):933-941. PubMed ID: 34773344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines.
    Schneider K; Bol V; Grégoire V
    Radiother Oncol; 2017 Sep; 124(3):411-417. PubMed ID: 28916224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
    Park SJ; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
    Oral Oncol; 2019 Aug; 95():127-135. PubMed ID: 31345380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
    Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma.
    Kwon M; Nam GH; Jung H; Kim SA; Kim S; Choi Y; Lee YS; Cho HJ; Kim IS
    Cancer Lett; 2021 Dec; 522():198-210. PubMed ID: 34571082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Protease Inhibitors Sensitize Human Head and Neck Squamous Carcinoma Cells to Radiation by Activating Endoplasmic Reticulum Stress.
    Liu R; Zhang L; Yang J; Zhang X; Mikkelsen R; Song S; Zhou H
    PLoS One; 2015; 10(5):e0125928. PubMed ID: 25933118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
    Poulose JV; Kainickal CT
    World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
    Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death.
    Shin YS; Cha HY; Lee BS; Kang SU; Hwang HS; Kwon HC; Kim CH; Choi EC
    Cancer Res Treat; 2016 Apr; 48(2):738-52. PubMed ID: 26511816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
    Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.